Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

GE HealthCare Technologies (GEHC) EBITDA (2022 - 2025)

Historic EBITDA for GE HealthCare Technologies (GEHC) over the last 4 years, with Q4 2025 value amounting to $827.0 million.

  • GE HealthCare Technologies' EBITDA rose 324.59% to $827.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $2.8 billion, marking a year-over-year increase of 525.71%. This contributed to the annual value of $2.8 billion for FY2025, which is 525.71% up from last year.
  • As of Q4 2025, GE HealthCare Technologies' EBITDA stood at $827.0 million, which was up 324.59% from $653.0 million recorded in Q3 2025.
  • GE HealthCare Technologies' EBITDA's 5-year high stood at $827.0 million during Q4 2025, with a 5-year trough of $509.0 million in Q1 2022.
  • In the last 4 years, GE HealthCare Technologies' EBITDA had a median value of $630.0 million in 2022 and averaged $646.6 million.
  • As far as peak fluctuations go, GE HealthCare Technologies' EBITDA plummeted by 1132.56% in 2023, and later surged by 1648.15% in 2025.
  • Quarter analysis of 4 years shows GE HealthCare Technologies' EBITDA stood at $777.0 million in 2022, then fell by 11.33% to $689.0 million in 2023, then rose by 16.26% to $801.0 million in 2024, then increased by 3.25% to $827.0 million in 2025.
  • Its EBITDA stands at $827.0 million for Q4 2025, versus $653.0 million for Q3 2025 and $654.0 million for Q2 2025.